• ABOUT ELITE
    • Overview
    • Our Facility
    • Management & Key Employees
    • Our Board
    • Careers
  • PRODUCTS
  • PIPELINE
    • Generic
    • Branded
  • TECHNOLOGY
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
logo image
HOME | CAREERS | CONTACT | NEWS |
Share
Skip to content
  • About Elite
    • Overview
    • Management & Key Employees
    • Our Board
    • Careers
  • Products
  • Pipeline
    • Generic
    • Branded
  • Technology
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • Investor Relations
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
    • Investor Relations
    • Press Releases
    • Events &
      Presentations
    • SEC Filings
    • Shareholder
      Meeting
    • Governance
      Documents
    • Investor Contacts
    • Email Alerts

Press Releases

 
Select:
Aug 04, 2004
Elite Pharmaceuticals Announces Exclusive Option to License its Technology Granted to Purdue Pharma has Lapsed

Jul 28, 2004
ELITE PHARMACEUTICALS INC. ANNOUNCES INCREASE IN AUTHORIZED SHARES OF CAPITAL STOCK

May 14, 2004
Elite Announces Appointment of its Chief Executive Officer as Chairman

May 10, 2004
Elite Grants Purdue Exclusive Right to Evaluate Its Abuse Resistance Drug Formulation Technology

May 03, 2004
Elite Pharmaceuticals Announces Closing of Settlement of Litigation with Former CEO

Apr 01, 2004
Elite Pharmaceuticals Announces Settlement of Litigation with Former CEO

Mar 09, 2004
Elite Pharmaceuticals Announces Extension of B Warrants

Mar 05, 2004
Elite Completes Registration Batches for Allergy Product

Dec 23, 2003
ELITE LABORATORIES AND PIVOTAL DEVELOPMENT ANNOUNCE COLLABORATION ON SUSTAINED RELEASE GENERIC PRODUCT

Dec 04, 2003
Elite Pharmaceuticals Completes $3,290,000 Private Placement

 21   22   23   24   25     26    27 
 <<   <   >   >> 
  • Site Map   |  Privacy  |  Terms Of Use
Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.
ART™: Abuse-Resistant Technology for a safer healthier you.
Back to top

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window